<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC6831721/table_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 1</label>
  <p>Origins of resistance in malaria parasite, 
   <i>Plasmodium falciparum</i>, to monotherapy drugs. 
  </p>
 </caption>
 <thead>
  <tr>
   <th valign="top" rowspan="1" colspan="1" id="0-0-.">Monotherapy application dates</th>
   <th valign="top" rowspan="1" colspan="1" id="0-1-.">Drug and its mechanism</th>
   <th valign="top" rowspan="1" colspan="1" id="0-2-.">Resistance and its mechanism</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td valign="top" rowspan="1" colspan="1">
    <b>∼1930–1950</b>
   </td>
   <td valign="top" rowspan="1" colspan="1">Chloroquine interferes with the detoxification of heme by accumulating in the digestive vacuole of 
    <i>Plasmodium</i> ( 
    <a rid="B50" ref-type="bibr">Haldar et al., 2018</a>). 
   </td>
   <td valign="top" rowspan="1" colspan="1">∼1950. Mutations in transporter genes enabling efflux of chloroquine: chloroquine resistance transporter (PfCRT) ( 
    <a rid="B74" ref-type="bibr">Martin et al., 2009</a>) ( 
    <a rid="B50" ref-type="bibr">Haldar et al., 2018</a>); chloroquine transporter (CG2) ( 
    <a rid="B50" ref-type="bibr">Haldar et al., 2018</a>); ABC transporter (PfMDR1) ( 
    <a rid="B50" ref-type="bibr">Haldar et al., 2018</a>). 
   </td>
  </tr>
  <tr>
   <td valign="top" rowspan="1" colspan="1">
    <b>1953</b>
   </td>
   <td valign="top" rowspan="1" colspan="1">Pyrimethamine and sulfadoxine inhibit folate pathway ( 
    <a rid="B48" ref-type="bibr">Gregson and Plowe, 2005</a>; 
    <a rid="B55" ref-type="bibr">Hyde, 2005</a>) by blocking dihydropteroate synthase (PfDhps) and dihydrofolate reductase (PfDhfr). 
   </td>
   <td valign="top" rowspan="1" colspan="1">2009 ( 
    <a rid="B46" ref-type="bibr">Gesase et al., 2009</a>). Mutations in and/or amplification of PfDhps and PfDhfr genes ( 
    <a rid="B93" ref-type="bibr">Shah et al., 2011</a>; 
    <a rid="B23" ref-type="bibr">Costa et al., 2017</a>). 
   </td>
  </tr>
  <tr>
   <td valign="top" rowspan="1" colspan="1">
    <b>∼1960</b>
   </td>
   <td valign="top" rowspan="1" colspan="1">Piperaquine interferes with the detoxification of heme by accumulating in the digestive vacuole of 
    <i>Plasmodium</i> ( 
    <a rid="B36" ref-type="bibr">Eastman and Fidock, 2009</a>). 
   </td>
   <td valign="top" rowspan="1" colspan="1">2010 ( 
    <a rid="B35" ref-type="bibr">Duru et al., 2016</a>). Amplification of parasite protease genes, such as plasmepsin 2 and 3 ( 
    <a rid="B50" ref-type="bibr">Haldar et al., 2018</a>). 
   </td>
  </tr>
  <tr>
   <td valign="top" rowspan="1" colspan="1">
    <b>1972</b>
   </td>
   <td valign="top" rowspan="1" colspan="1">Artemisinin suggested to interfere with the detoxification of heme ( 
    <a rid="B36" ref-type="bibr">Eastman and Fidock, 2009</a>). 
   </td>
   <td valign="top" rowspan="1" colspan="1">2008 ( 
    <a rid="B30" ref-type="bibr">Dondorp et al., 2009</a>). Mutations in transporter genes, such as PfK13, enabling efflux of Chloroquine; or a change in target recognized by the parasite ( 
    <a rid="B86" ref-type="bibr">Ouji et al., 2018</a>). 
   </td>
  </tr>
 </tbody>
</table>
